A comparison between different types of covalent DNA modifications (I-compounds, persistent carcinogen adducts and 5-methylcytosine) in regenerating rat liver
I-Compounds have been recently identified as adduct-like nonpolar covalent DNA modifications that are detectable by 32P-postlabeling assay in tissues of untreated experimental animals and increase with age. Additional I-compounds have now been observed in liver DNA of male Sprague-Dawley rats when t...
Saved in:
Published in | Carcinogenesis (New York) Vol. 9; no. 10; p. 1843 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
England
01.10.1988
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | I-Compounds have been recently identified as adduct-like nonpolar covalent DNA modifications that are detectable by 32P-postlabeling assay in tissues of untreated experimental animals and increase with age. Additional I-compounds have now been observed in liver DNA of male Sprague-Dawley rats when the chromatographic conditions were modified to allow for the detection of more polar adducts exhibiting low affinity to polyethyleneimine (PEI)--cellulose anion-exchange thin-layer material. The total I-compound level in 10-month-old animals was as high as one modification in approximately 10(7) nucleotides. This represented a minimum estimate since 100% recovery of all rat liver I-compounds in 32P-labeled form presumably was not achieved by the procedures used. The I-compound pattern was reproducible and variation of I-compound levels among individual animals of the same age was small. We have used regenerating rat liver herein as a model to compare the properties of I-compounds with those of persistent 2-acetylaminofluorene (AAF)-induced DNA adducts and of 5-methylcytosine (m5C), a normal enzymatic DNA modification. Eight- to 10-month-old male Sprague-Dawley rats were given 2-AAF (50 mg/kg in DMSO) or vehicle (DMSO) by i.p. injection. Partial hepatectomy was performed 6 weeks later (i.e. after AAF adduct levels had stabilized) and regenerating liver samples were taken 1 week after the operation for DNA analysis. Consistent with the restoration of cell and tissue loss, the overall levels of I-compounds and 2-AAF adducts were reduced to approximately 47% and approximately 45% respectively of control in regenerating liver by dilution with newly synthesized DNA, while the m5C level was not affected. Thus, in regenerating liver, I-compounds resembled carcinogen--DNA adducts and not m5C. This supports our hypothesis that the formation of these DNA modifications may be due to the binding to DNA of small amounts of reactive electrophilic by-products of normal metabolic activities, leading to the slow accumulation of I-compounds in tissue DNA with ageing. |
---|---|
AbstractList | I-Compounds have been recently identified as adduct-like nonpolar covalent DNA modifications that are detectable by 32P-postlabeling assay in tissues of untreated experimental animals and increase with age. Additional I-compounds have now been observed in liver DNA of male Sprague-Dawley rats when the chromatographic conditions were modified to allow for the detection of more polar adducts exhibiting low affinity to polyethyleneimine (PEI)--cellulose anion-exchange thin-layer material. The total I-compound level in 10-month-old animals was as high as one modification in approximately 10(7) nucleotides. This represented a minimum estimate since 100% recovery of all rat liver I-compounds in 32P-labeled form presumably was not achieved by the procedures used. The I-compound pattern was reproducible and variation of I-compound levels among individual animals of the same age was small. We have used regenerating rat liver herein as a model to compare the properties of I-compounds with those of persistent 2-acetylaminofluorene (AAF)-induced DNA adducts and of 5-methylcytosine (m5C), a normal enzymatic DNA modification. Eight- to 10-month-old male Sprague-Dawley rats were given 2-AAF (50 mg/kg in DMSO) or vehicle (DMSO) by i.p. injection. Partial hepatectomy was performed 6 weeks later (i.e. after AAF adduct levels had stabilized) and regenerating liver samples were taken 1 week after the operation for DNA analysis. Consistent with the restoration of cell and tissue loss, the overall levels of I-compounds and 2-AAF adducts were reduced to approximately 47% and approximately 45% respectively of control in regenerating liver by dilution with newly synthesized DNA, while the m5C level was not affected. Thus, in regenerating liver, I-compounds resembled carcinogen--DNA adducts and not m5C. This supports our hypothesis that the formation of these DNA modifications may be due to the binding to DNA of small amounts of reactive electrophilic by-products of normal metabolic activities, leading to the slow accumulation of I-compounds in tissue DNA with ageing. |
Author | Li, D Lu, L J Randerath, K |
Author_xml | – sequence: 1 givenname: K surname: Randerath fullname: Randerath, K organization: Department of Pharmacology, Baylor College of Medicine, Houston, TX 77030 – sequence: 2 givenname: L J surname: Lu fullname: Lu, L J – sequence: 3 givenname: D surname: Li fullname: Li, D |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/3168163$$D View this record in MEDLINE/PubMed |
BookMark | eNotkE1LAzEQhnOo1Fq9exFyVHDbTbJfOZb6VSh60XPJJpMa2U2WJK3sn_G3uksLA-_w8vAwzBWaWGcBoVuSLkjK2VIKL41d8sVYVBmboFlKMpYwxrJLdBXCT5qSguV8iqaMFNWwz9DfCkvXdsKb4CyuIf4CWKyM1uDBRhz7DgJ2eqCOohmbp_cVbt1AGCmicTbg-00yOtzBqvCIO_DBhDiip4vcfjAKpQ4yBiyswnnSQvzuG9lHF4yFB2ws9jBg4Ael3eMhcGOO4K_RhRZNgJtzztHXy_Pn-i3Zfrxu1qttIhmnMcmloppQwnRVMZWB5pLyEvJKpzXllNVQl3layFJkTJWFkJoVhJa6IlTycebo7uTtDnULatd50wrf785_ov_6B26b |
CitedBy_id | crossref_primary_10_1016_0165_1218_95_90001_2 crossref_primary_10_1016_S0027_5107_99_00009_3 crossref_primary_10_1093_jn_121_1_65 crossref_primary_10_1111_j_1440_1746_1990_tb01633_x crossref_primary_10_1002__SICI_1098_2744_200001_27_1_34__AID_MC6_3_0_CO_2_G crossref_primary_10_1016_0531_5565_95_02027_6 crossref_primary_10_1016_S1383_5742_97_00041_0 crossref_primary_10_1016_S0027_5107_98_00211_5 crossref_primary_10_1006_bbrc_1999_1528 crossref_primary_10_1111_j_1349_7006_1989_tb01722_x crossref_primary_10_1016_0009_2797_94_03338_2 crossref_primary_10_1016_0531_5565_92_90008_N crossref_primary_10_1016_0921_8734_89_90023_4 crossref_primary_10_1016_0009_2797_90_90101_R crossref_primary_10_1016_0165_1110_90_90016_5 crossref_primary_10_1006_rtph_2000_1430 crossref_primary_10_1016_0041_008X_92_90117_B crossref_primary_10_1016_0047_6374_91_90099_L crossref_primary_10_1016_0300_483X_91_90075_C crossref_primary_10_1016_0921_8734_90_90001_8 crossref_primary_10_1016_0300_483X_90_90167_F crossref_primary_10_1016_S0027_5107_99_00018_4 crossref_primary_10_1016_0009_2797_92_90126_6 crossref_primary_10_1016_0009_2797_93_90090_L crossref_primary_10_1016_0921_8734_93_90009_R crossref_primary_10_1080_01635589209514189 crossref_primary_10_1016_0165_1218_95_90098_5 crossref_primary_10_1016_0921_8734_93_90024_W crossref_primary_10_1016_0027_5107_91_90169_O crossref_primary_10_1016_0921_8734_93_90007_P crossref_primary_10_3109_03602539409029785 crossref_primary_10_1016_0027_5107_93_90077_S crossref_primary_10_1007_BF00928150 crossref_primary_10_1016_0165_1161_93_90154_R crossref_primary_10_1016_j_freeradbiomed_2004_05_024 crossref_primary_10_1016_0027_5107_91_90034_L crossref_primary_10_1016_S0278_6915_96_00045_2 crossref_primary_10_1158_1055_9965_EPI_04_0759 crossref_primary_10_1002_em_2850160203 crossref_primary_10_1016_0921_8734_90_90028_P crossref_primary_10_1016_0921_8734_92_90008_D crossref_primary_10_1016_0165_1110_90_90020_C crossref_primary_10_1016_0006_291X_92_91592_E crossref_primary_10_1016_0304_3835_93_90076_L |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1093/carcin/9.10.1843 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
ExternalDocumentID | 3168163 |
Genre | Research Support, U.S. Gov't, P.H.S Journal Article |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: R37-CA 32157 |
GroupedDBID | --- -E4 .2P .55 .GJ .I3 .ZR 0R~ 18M 1TH 29B 2WC 3O- 4.4 482 48X 53G 5GY 5RE 5VS 5WA 5WD 6.Y 6J9 70D A8Z AABZA AACZT AAIMJ AAJKP AAJQQ AAMDB AAMVS AAOGV AAPGJ AAPNW AAPQZ AAPXW AARHZ AAUAY AAUQX AAVAP AAVLN AAWDT ABEFU ABEUO ABIXL ABJNI ABKDP ABLJU ABMNT ABNHQ ABNKS ABPTD ABQLI ABQTQ ABSAR ABSMQ ABWST ABXVV ABZBJ ACFRR ACGFO ACGFS ACMRT ACNCT ACPQN ACPRK ACUFI ACUTJ ACUTO ACZBC ADBBV ADEYI ADEZT ADFTL ADGKP ADGZP ADHKW ADHZD ADIPN ADJQC ADOCK ADQBN ADRIX ADRTK ADVEK ADYVW ADZTZ ADZXQ AEGPL AEGXH AEHUL AEJOX AEKPW AEKSI AELWJ AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFNX AFFZL AFGWE AFIYH AFOFC AFRAH AFSHK AFXEN AFYAG AGINJ AGKEF AGKRT AGMDO AGQXC AGSYK AHMBA AHXPO AIAGR AIJHB AJEEA AKHUL AKWXX ALMA_UNASSIGNED_HOLDINGS ALUQC ANFBD APIBT APJGH APWMN AQDSO AQKUS ARIXL ASAOO ASPBG ATDFG ATGXG ATTQO AVNTJ AVWKF AXUDD AYOIW AZFZN BAWUL BAYMD BCRHZ BEYMZ BHONS BQDIO BSWAC BTRTY BVRKM BZKNY C1A C45 CAG CDBKE CGR COF CS3 CUY CVF CXTWN CZ4 DAKXR DFGAJ DIK DILTD DU5 D~K E3Z EBD EBS ECM EE~ EIF EIHJH EJD ELUNK EMOBN ESTFP F5P F9B FEDTE FHSFR FLUFQ FOEOM FOTVD FQBLK FRP GAUVT GJXCC GX1 H13 H5~ HAR HVGLF HW0 HZ~ IH2 IOX J21 KAQDR KBUDW KOP KQ8 KSI KSN M-Z M49 MBLQV MBTAY N9A NGC NLBLG NOMLY NOYVH NPM NTWIH NU- NVLIB O0~ O9- OAWHX OBOKY OCZFY ODMLO OJQWA OJZSN OK1 OPAEJ OVD OWPYF O~Y P2P PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD R44 RD5 RHF RIG RNI ROL ROX ROZ RUSNO RW1 RXO RZF RZO SV3 TCN TEORI TJX TLC TMA TR2 W8F WOQ X7H X7M XOL YAYTL YKOAZ YXANX ZGI ZKB ZKX ZXP ~91 |
ID | FETCH-LOGICAL-c392t-5cd2f1213f883d4ef9c297e58f0b2923beb7506c7a43d76acf36127f812c92c92 |
ISSN | 0143-3334 |
IngestDate | Wed Oct 16 00:56:42 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c392t-5cd2f1213f883d4ef9c297e58f0b2923beb7506c7a43d76acf36127f812c92c92 |
PMID | 3168163 |
ParticipantIDs | pubmed_primary_3168163 |
PublicationCentury | 1900 |
PublicationDate | 1988-10-01 |
PublicationDateYYYYMMDD | 1988-10-01 |
PublicationDate_xml | – month: 10 year: 1988 text: 1988-10-01 day: 01 |
PublicationDecade | 1980 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Carcinogenesis (New York) |
PublicationTitleAlternate | Carcinogenesis |
PublicationYear | 1988 |
SSID | ssj0016359 |
Score | 1.582942 |
Snippet | I-Compounds have been recently identified as adduct-like nonpolar covalent DNA modifications that are detectable by 32P-postlabeling assay in tissues of... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 1843 |
SubjectTerms | 2-Acetylaminofluorene - metabolism 5-Methylcytosine Adenosine Triphosphate - metabolism Animals Body Weight Cytosine - analogs & derivatives Cytosine - analysis DNA - metabolism Liver - metabolism Liver Regeneration Male Organ Size Phosphorus Radioisotopes Rats Rats, Inbred Strains Reference Values |
Title | A comparison between different types of covalent DNA modifications (I-compounds, persistent carcinogen adducts and 5-methylcytosine) in regenerating rat liver |
URI | https://www.ncbi.nlm.nih.gov/pubmed/3168163 |
Volume | 9 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LSxxBEG7WBIOXkIeSGJU65JCgrePOo2eOizFI0D0EBW_SzyDo7IKzB_0xXvyjqerunRkXQ0xgmVm6h57ero_a6uqvqhj7LNGEVfuJ5plylme5FlxSwkspCydzJarEkB_yZFwcnWU_zvPzweChx1qaNWpX3z0ZV_I_UsU2lCtFyf6DZNtBsQG_o3zxihLG67NkPIoUcl9GcM64mpc8abx79SbwxvGt1PJtPKLaN0QPihQ4MjA5jULllbxMp-RBQ9nj45oKDdUTfP82KqgZ8T7Iz55zqjt9e6Vvm8lNSFQawmJ--RzWnkiNt-0r4nz0rd-DdjxLeVAeFQJqHRI_fbyNDP6e1gl7PPMehO4U6_iy4yubEMZXli3_rXNkpjxNoyMzauKqD7ikp1apKM2T-j7kwgqrQVyPXWpceBhlNr32CKAiXfvF3zsXMnDHniW2JEpSpWNyCMWDKrTXqsCSDT8nnoTjvPbCrPbaOa2w5TjSwhbGmzKnb9jruAeBUQDUWzaw9Tv26iSyLN6z-xF0uIKIK2hxBR5XMHEwxxUgruARruBLD1U70GEKOkxBxBSgwGERU1_hsoY-ogBv4BG1ys6-H54eHPFYx4NrtL4bnmszdJQ60JVlajLrKj2shM1Ll6ghbjCUVWi3FlrILDWikNqlaHcLh7anruizxl7Uk9p-YGCNKpUuhbamyNRQVTLL8F9HpiYxRij1ka2Flb2YhmQtF3HJ1__U8YmtdPjcYC8d6ga7iYZmo7a8qH8DH02B6Q |
link.rule.ids | 783 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+comparison+between+different+types+of+covalent+DNA+modifications+%28I-compounds%2C+persistent+carcinogen+adducts+and+5-methylcytosine%29+in+regenerating+rat+liver&rft.jtitle=Carcinogenesis+%28New+York%29&rft.au=Randerath%2C+K&rft.au=Lu%2C+L+J&rft.au=Li%2C+D&rft.date=1988-10-01&rft.issn=0143-3334&rft.volume=9&rft.issue=10&rft.spage=1843&rft_id=info:doi/10.1093%2Fcarcin%2F9.10.1843&rft_id=info%3Apmid%2F3168163&rft_id=info%3Apmid%2F3168163&rft.externalDocID=3168163 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0143-3334&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0143-3334&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0143-3334&client=summon |